THE DIFFERENTIATION SYNDROME IN PATIENTS WITH ACUTE PROMYELOCYTIC LEUKEMIA: EXPERIENCE OF THE PETHEMA GROUP AND REVIEW OF THE LITERATURE.

THE DIFFERENTIATION SYNDROME IN PATIENTS WITH ACUTE PROMYELOCYTIC LEUKEMIA: EXPERIENCE OF THE PETHEMA GROUP AND REVIEW OF THE LITERATURE.

Show other versions (1)

Differentiation syndrome (DS), formerly known as retinoic acid syndrome, is the main life-threatening complication of therapy with differentiating agents (all-trans retinoic acid [ATRA] or arsenic trioxide [ATO]) in patients with acute promyelocytic leukemia (APL). The differentiation of leukemic bl...

Full description

Bibliographic Details
Main Authors: Pau Montesinos, Miguel A Sanz
Format: Article
Language:English
Published: PAGEPress Publications 2011-12-01
Series:Mediterranean Journal of Hematology and Infectious Diseases
Subjects:
Leukemia, Acute Promyelocytic Leukemia
Differentiation Syndrome, ATRA, Tetinoic Acid
Online Access:http://www.mjhid.org/index.php/mjhid/article/view/312

Internet

http://www.mjhid.org/index.php/mjhid/article/view/312

Similar Items